Intelligent Investor

Amplia Therapeutics Limited (ASX: ATX) - Announcements

- Current share price for ATX : $0.060

ASX company news and announcements for Amplia Therapeutics Limited (ATX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Amplia Therapeutics Limited (ATX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Amplia Therapeutics Limited (ATX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Amplia Therapeutics Limited (ATX)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$12 AACR Ovarian Cancer Conference Presentation 9 Oct 2023 8:55AM $0.088 $0.060 $0.062 fallen by 31.82%
$12 AACR Pancreatic Cancer Conference Presentation 29 Sep 2023 8:20AM $0.079 $0.060 $0.062 fallen by 24.05%
$12 New Chief Financial Officer Mr Tim Luscombe 25 Sep 2023 8:50AM $0.084 $0.060 $0.062 fallen by 28.57%
$12 Notification of cessation of securities - ATX 4 Sep 2023 12:51PM $0.080 $0.060 $0.062 fallen by 25%
$12 Notification of cessation of securities - ATX 1 Sep 2023 10:22AM $0.088 $0.060 $0.062 fallen by 31.82%
$12 Change of Director's Interest Notice - Dr Robert Peach 1 Sep 2023 10:17AM $0.088 $0.060 $0.062 fallen by 31.82%
$12 Change of Director's Interest Notice - Dr Christopher Burns 29 Aug 2023 4:50PM $0.088 $0.060 $0.062 fallen by 31.82%
$12 Notification regarding unquoted securities - ATX 29 Aug 2023 4:17PM $0.088 $0.060 $0.062 fallen by 31.82%
$12 Results of Annual General Meeting 24 Aug 2023 11:58AM $0.080 $0.060 $0.062 fallen by 25%
$12 CEO and MD Presentation to Annual General Meeting 24 Aug 2023 10:24AM $0.080 $0.060 $0.062 fallen by 25%
$12 ACCENT Trial Recruitment Update 2 Aug 2023 8:33AM $0.087 $0.060 $0.062 fallen by 31.03%
$12 ATX Quarterly Activities and Cashflow Reports - June 23 Qtr 31 Jul 2023 8:18AM $0.085 $0.060 $0.062 fallen by 29.41%
$12 Notice of Annual General Meeting/Proxy Form 21 Jul 2023 4:58PM $0.078 $0.060 $0.062 fallen by 23.08%
$12 ATX - Shareholder Newsletter July 2023 20 Jul 2023 9:52AM $0.081 $0.060 $0.062 fallen by 25.93%
$12 Application for quotation of securities - ATX 12 Jul 2023 5:24PM $0.084 $0.060 $0.062 fallen by 28.57%
$12 AMP945 International Nonproprietary Name Narmafotinib 21 Jun 2023 8:34AM $0.090 $0.060 $0.062 fallen by 33.33%
$12 Amplia AGM to be held Thursday 24 August 2023 19 Jun 2023 5:34PM $0.083 $0.060 $0.062 fallen by 27.71%
$12 Key to Corporate Governance Disclosures 31 May 2023 8:14AM $0.089 $0.060 $0.062 fallen by 32.58%
$12 2023 Corporate Governance Statement 30 May 2023 5:12PM $0.089 $0.060 $0.062 fallen by 32.58%
$12 Annual Report to Shareholders 30 May 2023 5:11PM $0.089 $0.060 $0.062 fallen by 32.58%
$12 AMP945 and FOLFIRINOX active in model of Pancreatic Cancer 29 May 2023 8:42AM $0.085 $0.060 $0.062 fallen by 29.41%
$12 Grant to collaborate with CSIRO Supplementary Announcement 23 May 2023 11:22AM $0.091 $0.060 $0.062 fallen by 34.07%
$12 Amplia receives grant to collaborate with CSIRO 22 May 2023 8:24AM $0.085 $0.060 $0.062 fallen by 29.41%
$12 ACCENT Trial Recruitment Progress 9 May 2023 11:44AM $0.100 $0.060 $0.062 fallen by 40%
$12 Quarterly Activities and Cashflow Reports - March 23 Qtr 26 Apr 2023 10:03AM $0.105 $0.060 $0.062 fallen by 42.86%

26 - 50 of 346 results

Page 2 of 14

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.